Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 6.43x is 100% below its 1-year average of 2303.96x, near the low end of its 1-year range (6.43x–4601.50x).
As of the fiscal period ended Saturday, December 31, 2022. 99.72% below its 12-month average of 2303.96x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-12-31): 6.43x.
INTEREST COVERAGE RATIO
6.43x
INTEREST COVERAGE RATIO AVG TTM
2303.96x
INTEREST COVERAGE RATIO AVG 3Y
2303.96x
INTEREST COVERAGE RATIO AVG 5Y
2303.96x
INTEREST COVERAGE RATIO AVG 10Y
-832.78x
INTEREST COVERAGE RATIO AVG 15Y
-348.51x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-99.72%
CURRENT VS 3Y AVG
-99.72%
CURRENT VS 5Y AVG
-99.72%
CURRENT VS 10Y AVG
+100.77%
CURRENT VS 15Y AVG
+101.84%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+200.81%
vs the sector median at left
Gyre Therapeutics, Inc.
Market Cap
$787.11M
Interest Coverage Ratio
6.43x
TTM Avg
2303.96x
3Y Avg
2303.96x
5Y Avg
2303.96x
Market Cap
$781.24M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$779.45M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$779.25M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$777.80M
Interest Coverage Ratio
-0.78x
TTM Avg
1.83x
3Y Avg
1.88x
5Y Avg
1.58x
Market Cap
$772.26M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$802.74M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $787.11M | 6.43x | 2303.96x | 2303.96x | 2303.96x |
| AdaptHealth Corp. (AHCO)vs › | $781.24M | 1.76x | 1.92x | 1.86x | 1.93x |
| Geron Corporation (GERN)vs › | $779.45M | -1.65x | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $779.25M | -5.87x | 6.84x | 6.84x | 3.53x |
| Varex Imaging Corporation (VREX)vs › | $777.80M | -0.78x | 1.83x | 1.88x | 1.58x |
| Sana Biotechnology, Inc. (SANA)vs › | $772.26M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $802.64M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $802.74M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $808.55M | -1.44x | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $763.14M | 1.73x | 1.55x | 1.27x | 1.31x |
Interest Coverage
6.4x
Debt/Equity
0.03
Current Ratio
4.26
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-12-31 | 6.43x |
| 2022-09-30 | 4601.50x |
| 2015-09-30 | -2.70x |
| 2014-12-31 | 5824.67x |
| 2014-09-30 | -997.60x |
| 2014-06-30 | -1373.17x |
| 2014-03-31 | -1306.22x |
| 2013-12-31 | -1330.80x |
| 2013-09-30 | -1011.23x |
| 2013-06-30 | -892.00x |
| 2013-03-31 | -517.13x |
| 2012-12-31 | -903.33x |
| 2012-09-30 | -404.90x |
| 2012-06-30 | 647.00x |
| 2012-03-31 | 76.38x |
| 2011-12-31 | -307.42x |
| 2011-09-30 | -239.26x |
| 2011-06-30 | -88.66x |
| 2011-03-31 | 396.84x |
| 2010-12-31 | -34.79x |
| 2010-09-30 | 71.09x |
| 2010-06-30 | 130.68x |
| 2010-03-31 | 168.79x |
| 2009-12-31 | -566.43x |
| 2009-09-30 | 22.72x |
| 2009-06-30 | -172.88x |
| 2009-03-31 | -84.20x |
